List of Tables
Table 1 Decentralised Clinical Trials Market Snapshot, 2026 & 2036 (US$ Million, CAGR %)
Table 2 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
Table 3 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
Table 4 Decentralised Clinical Trials Market Forecast by Region 2026-2036 (US$ Billion, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
Table 5 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 6 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 7 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 8 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 9 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 10 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 11 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 12 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 13 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 15 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 16 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 17 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 18 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 19 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 20 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 21 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 22 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 23 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 25 Decentralised Clinical Trials Market Forecast by Region, 2026-2036 (US$ Million, AGR%, CAGR%)
Table 26 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 27 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 28 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 29 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 30 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 38 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 39 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 40 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 41 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 42 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 43 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 44 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 45 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 46 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 47 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 48 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 49 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 50 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 54 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 55 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 56 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 57 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 58 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 59 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 60 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 61 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 62 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 65 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 66 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 67 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 68 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 69 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 70 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 71 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 72 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 73 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 74 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 75 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 76 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 77 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 78 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 79 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 80 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 81 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 82 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 83 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR%, CAGR%)
Table 84 Strategic Outlook
Table 85 4G Clinical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 4G Clinical: Product Benchmarking
Table 87 4G Clinical: Strategic Outlook
Table 88 Advarra Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Advarra Inc.: Product Benchmarking
Table 90 Advarra: Strategic Outlook
Table 91 Castor: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Castor: Solutions Benchmarking
Table 93 Castor: Strategic Outlook
Table 94 Clario: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Clario: Solutions Benchmarking
Table 96 Clario: Strategic Outlook
Table 97 Clinical Ink: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Clinical Ink: Solutions Benchmarking
Table 99 Clinical Ink: Strategic Outlook
Table 100 Cloudzbyz, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Cloudzbyz, Inc.: Product Benchmarking
Table 102 Cloudzbyz, Inc.: Strategic Outlook
Table 103 Dassault Systemes SE (Medidata Solutions, Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Dassault Systemes SE (Medidata Solutions, Inc.): Product Benchmarking
Table 105 Dassault Systemes SE (Medidata Solutions, Inc.): SWOT Analysis
Table 106 Dassault Systemes SE (Medidata Solutions, Inc.): Strategic Outlook
Table 107 Ergomed Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Ergomed Group: Product Benchmarking
Table 109 Ergomed Group: Strategic Outlook
Table 110 Florence Healthcare, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Florence Healthcare, Inc.: Product Benchmarking
Table 112 Florence Healthcare, Inc.: Strategic Outlook
Table 113 Icon Plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Icon Plc: Product Benchmarking
Table 115 Icon Plc: SWOT Analysis
Table 116 Icon Plc: Strategic Outlook
Table 117 Iqvia Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Iqvia Inc.: Product Benchmarking
Table 119 Iqvia Inc.: SWOT Analysis
Table 120 Iqvia Inc.: Strategic Outlook
Table 121 KORE Wireless Group, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 KORE Wireless Group, Inc.: Product Benchmarking
Table 123 KORE Wireless Group, Inc.: SWOT Analysis
Table 124 KORE Wireless Group, Inc.: Strategic Outlook
Table 125 Labcorp Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Labcorp Holdings: Product Benchmarking
Table 127 Labcorp Holdings: SWOT Analysis
Table 128 Labcorp Holdings: Strategic Outlook
Table 129 Medable Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Medable Inc.: Product Benchmarking
Table 131 Medable Inc.: Strategic Outlook
Table 132 Medrio, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Medrio, Inc.: Product Benchmarking
Table 134 Medrio, Inc.: Strategic Outlook
Table 135 Novotech Health Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Novotech Health Holdings: Product Benchmarking
Table 137 Novotech Health Holdings: Strategic Outlook
Table 138 Oracle Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Oracle Life Sciences: Product Benchmarking
Table 140 Oracle Life Sciences: SWOT Analysis
Table 141 Oracle Corporation: Strategic Outlook
Table 142 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 Parexel International (MA) Corporation: Product Benchmarking
Table 144 Parexel International (MA) Corporation: SWOT Analysis
Table 145 Parexel International (MA) Corporation: Strategic Outlook
Table 146 ProPharma Group MIS Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 ProPharma Group MIS Limited: Product Benchmarking
Table 148 ProPharma Group MIS Limited: Strategic Outlook
Table 149 Science 37 Holdings, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Science 37 Holdings, Inc.: Product Benchmarking
Table 151 Science 37 Holdings, Inc.: Strategic Outlook
Table 152 Signant Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 153 Signant Health: Product Benchmarking
Table 154 Signant Health: Strategic Outlook
Table 155 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 156 Syneos Health: Product Benchmarking
Table 157 Syneos Health: Strategic Outlook
Table 158 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 159 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 160 Thermo Fisher Scientific Inc.: SWOT Analysis
Table 161 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 162 TFS HealthScience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 163 TFS HealthScience: Product Benchmarking
Table 164 TFS HealthScience: Strategic Outlook
Table 165 THREAD Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 THREAD Research: Product Benchmarking
Table 167 THREAD Research: Strategic Outlook
Table 168 Veeva Systems Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Veeva Systems Inc.: Product Benchmarking
Table 170 Veeva Systems Inc.: SWOT Analysis
Table 171 Veeva Systems Inc.: Strategic Outlook
List of Figures
Figure 1 Decentralised Clinical Trials Market Segmentation
Figure 2 Decentralised Clinical Trials Market by Study-Design: Market Attractiveness Index
Figure 3 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 4 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 5 Decentralised Clinical Trials Market by End-users: Market Attractiveness Index
Figure 6 Decentralised Clinical Trials Market by Region: Market Attractiveness Index
Figure 7 Decentralised Clinical Trials Market: Market Dynamics
Figure 8 Decentralised Clinical Trials Market: Impact Analysis
Figure 9 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Decentralised Clinical Trials Market: Porter’s Five Forces Analysis
Figure 16 Decentralised Clinical Trials Market: PEST Analysis
Figure 17 Decentralised Clinical Trials Market by Study Design: Market Attractiveness Index
Figure 18 Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 19 Decentralised Clinical Trials Market Share Forecast by Study Design, 2026, 2031, 2036 (%)
Figure 20 Interventional Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 21 Interventional Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 22 Observational Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 23 Observational Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 Expanded Access Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 25 Expanded Access Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 Decentralised Clinical Trials Market by Indication: Market Attractiveness Index
Figure 27 Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 28 Decentralised Clinical Trials Market Share Forecast by Indication, 2026, 2031, 2036 (%)
Figure 29 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 30 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 31 Cardiovascular Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 32 Cardiovascular Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Immunology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 34 Immunology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Respiratory Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 36 Respiratory Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 38 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Decentralised Clinical Trials Market by Technology: Market Attractiveness Index
Figure 40 Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 41 Decentralised Clinical Trials Market Share Forecast by Technology, 2026, 2031, 2036 (%)
Figure 42 Telemedicine Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 43 Telemedicine Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Mobile Healthcare Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 45 Mobile Healthcare Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Wearable Devices Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 47 Wearable Devices Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Web-based Technology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 49 Web-based Technology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Decentralised Clinical Trials Market by End-User: Market Attractiveness Index
Figure 53 Decentralised Clinical Trials Market Forecast by End-User, 2026-2036 (US$ Billion, AGR %)
Figure 54 Decentralised Clinical Trials Market Share Forecast by End-User, 2026, 2031, 2036 (%)
Figure 55 Pharmaceutical and Biopharmaceutical Companies Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 56 Pharmaceutical and Biopharmaceutical Companies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Clinical Research Organisations (CROs) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 58 Clinical Research Organisations (CROs) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Others Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Decentralised Clinical Trials Market Forecast by Region 2025 and 2036 (Revenue, CAGR%)
Figure 62 Decentralised Clinical Trials Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 63 Decentralised Clinical Trials Market by Region, 2026-2036 (US$ Billion, AGR %)
Figure 64 North America Decentralised Clinical Trials Market Attractiveness Index
Figure 65 North America Decentralised Clinical Trials Market by Region, 2025, 2031 & 2036 (US$ Billion)
Figure 66 North America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 67 North America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 68 North America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 69 North America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 70 North America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 71 North America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 72 North America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 73 North America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 74 North America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 75 North America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 76 U.S. Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 77 Canada Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 78 Europe Decentralised Clinical Trials Market Attractiveness Index
Figure 79 Europe Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 80 Europe Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 81 Europe Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 82 Europe Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 83 Europe Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 84 Europe Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 85 Europe Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 86 Europe Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 87 Europe Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 88 Europe Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 89 Europe Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 90 Germany Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 91 France Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 92 UK Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 93 Italy Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 94 Spain Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 95 Russia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 96 Poland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 97 Belgium Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 98 Switzerland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 99 Netherland Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 100 Rest of Europe Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 101 Asia Pacific Decentralised Clinical Trials Market Attractiveness Index
Figure 102 Asia Pacific Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 103 Asia Pacific Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 104 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 105 Asia Pacific Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 106 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 107 Asia Pacific Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 108 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 109 Asia Pacific Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 110 Asia Pacific Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 111 Asia Pacific Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 112 Asia Pacific Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 113 Japan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 114 China Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 115 India Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 116 Australia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 117 South Korea Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 118 Singapore Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 119 Taiwan Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 120 New Zealand Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 121 Malaysia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 122 Rest of Asia Pacific Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 123 Latin America Decentralised Clinical Trials Market Attractiveness Index
Figure 124 Latin America Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 125 Latin America Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 126 Latin America Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 127 Latin America Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 128 Latin America Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 129 Latin America Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 130 Latin America Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 131 Latin America Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 132 Latin America Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 133 Latin America Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 134 Latin America Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 135 Brazil Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 136 Mexico Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 137 Argentina Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 138 Colombia Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 139 Chile Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 140 Rest of Latin America Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 141 MEA Decentralised Clinical Trials Market Attractiveness Index
Figure 142 MEA Decentralised Clinical Trials Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 143 MEA Decentralised Clinical Trials Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 144 MEA Decentralised Clinical Trials Market Share Forecast by Country, 2026 & 2036 (%)
Figure 145 MEA Decentralised Clinical Trials Market Forecast by Study Design, 2026-2036 (US$ Billion, AGR %)
Figure 146 MEA Decentralised Clinical Trials Market Share Forecast by Study Design, 2026 & 2036 (%)
Figure 147 MEA Decentralised Clinical Trials Market Forecast by Indication, 2026-2036 (US$ Billion, AGR %)
Figure 148 MEA Decentralised Clinical Trials Market Share Forecast by Indication, 2026 & 2036 (%)
Figure 149 MEA Decentralised Clinical Trials Market Forecast by Technology, 2026-2036 (US$ Billion, AGR %)
Figure 150 MEA Decentralised Clinical Trials Market Share Forecast by Technology, 2026 & 2036 (%)
Figure 151 MEA Decentralised Clinical Trials Market Forecast by End-users, 2026-2036 (US$ Billion, AGR %)
Figure 152 MEA Decentralised Clinical Trials Market Share Forecast by End-users, 2026 & 2036 (%)
Figure 153 GCC Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 154 South Africa Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 155 Egypt Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 156 Rest of MEA Decentralised Clinical Trials Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 157 Decentralised Clinical Trials Market: Company Share/Ranking, 2024
Figure 158 Dassault Systemes SE (Medidata Solutions, Inc.): Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 159 Dassault Systemes SE (Medidata Solutions, Inc.): R&D, 2021-2024 (US$ Million, AGR%)
Figure 160 Dassault Systemes SE (Medidata Solutions, Inc.): Regional Market Shares, 2024
Figure 161 Dassault Systemes SE (Medidata Solutions, Inc.): Business Segment Market Shares, 2024
Figure 162 Icon Plc: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 163 Icon Plc: Regional Market Shares, 2024
Figure 164 Iqvia Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 165 Iqvia Inc.: Regional Market Shares, 2024
Figure 166 Iqvia Inc.: Business Segment Market Shares, 2025
Figure 167 KORE Wireless Group, Inc.: Net Revenue, 2021-2024 (US$ Million, AGR%)
Figure 168 KORE Wireless Group, Inc.: Regional Market Shares, 2024
Figure 169 KORE Wireless Group, Inc.: Business Segment Market Shares, 2024
Figure 170 Labcorp Holdings: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 171 Labcorp Holdings: Regional Market Shares, 2024
Figure 172 Labcorp Holdings: Business Segment Market Shares, 2024
Figure 173 Oracle Life Sciences: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 174 Oracle Life Sciences: R&D, 2022-2025 (US$ Million, AGR%)
Figure 175 Oracle Life Sciences: Regional Market Shares, 2025
Figure 176 Oracle Life Sciences: Business Segment Market Shares, 2025
Figure 177 Thermo Fisher Scientific Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 178 Thermo Fisher Scientific Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 179 Thermo Fisher Scientific Inc.: Regional Market Shares, 2024
Figure 180 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2024
Figure 181 Veeva Systems Inc.: Net Revenue, 2022-2025 (US$ Million, AGR%)
Figure 182 Veeva Systems Inc.: R&D, 2022-2025 (US$ Million, AGR%)
Figure 183 Veeva Systems Inc.: Regional Market Shares, 2025
Figure 184 Veeva Systems Inc.: Business Segment Market Shares, 2025
